Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002126698 | SCV002460643 | benign | not provided | 2024-11-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004656889 | SCV005148116 | uncertain significance | Inborn genetic diseases | 2024-06-19 | criteria provided, single submitter | clinical testing | The c.104C>T (p.A35V) alteration is located in exon 1 (coding exon 1) of the P4HB gene. This alteration results from a C to T substitution at nucleotide position 104, causing the alanine (A) at amino acid position 35 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003903533 | SCV004727591 | likely benign | P4HB-related disorder | 2023-10-11 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |